Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02044978
Other study ID # Tandskruv tidsserie
Secondary ID
Status Recruiting
Phase Phase 2
First received January 22, 2014
Last updated June 8, 2015
Start date January 2014
Est. completion date January 2017

Study information

Verified date June 2015
Source University Hospital, Linkoeping
Contact Jahan Abtahi, MD, PhD
Email jahan.abtahi@lio.se
Is FDA regulated No
Health authority Sweden: The National Board of Health and Welfare
Study type Interventional

Clinical Trial Summary

16 patients will be included. Each patient receives 2 dental implants. One of them is coated with a drug, zoledronate, to improve fixation. Fixation is measured by vibration resonance frequency analysis at insertion and 2, 4, 6 and 8 weeks after insertion.The 2 implants in each patient are compared. We expect to find an early improvement (higher resonance frequency) in the coated implant.


Description:

The zoledronate is linked to the titanium implant surface via a nanolayer of crosslinked fibrinigen. Resonance frequency is measured with standard clinical equipment (Ostell apparatus).


Recruitment information / eligibility

Status Recruiting
Enrollment 16
Est. completion date January 2017
Est. primary completion date January 2016
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

Need for dental implant in upper jaw. CTscan showing at least 6 mm bucco-lingual thickness. Generally healthy

Exclusion Criteria:

Drugs or conditions that influence or are thought to influence bone healing, such as bisphosphonates, corticosteroids, other oral pathologies, severe autoimmune diseases, cancer. Osteoporosis is not cause for exclusion.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Pre-integration Failure of Dental Implant

Intervention

Device:
Zoledronate-coated dental implant


Locations

Country Name City State
Sweden Käkcentralen Linköping
Sweden Tandläkarhuset Linköping

Sponsors (1)

Lead Sponsor Collaborator
Per Aspenberg

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Vibration frequency ratio Each patients has a study implant and a control implant. Their change vibation frequency from insertion till measurement time point is measured and the ratio between changes for the 2 implants forms the outcome measure. Avarage values for 4 and 6 weeks will be used. 4 and 6 weeks No
Secondary Marginal resorption Radiographic loss of bone at the margin of the implant, measured as difference in mm from the superficial bone contour between insertion and 8 weeks. 8 weeks No
Secondary Vibration: area under the curve Each patients has a study implant and a control implant. Their change vibation frequency from insertion till measurement time point is measured and the ratio between changes for the 2 implants forms the outcome measure. Avarage values for all weeks will be used. 2-8 weeks No